A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2011
10/05/2011	EP1179984B2 Process for manufacturing a product for enhancing immune response in companion animal using a combination of antioxidants
10/05/2011	CN1617704B Composition comprising at least one oxazolin for inhibiting langerhans cell migration, and uses thereof
10/05/2011	CN102209705A Crystalline forms of fingolimod hcl
10/05/2011	CN102206667A Recombinant plasmid pET32a-hIL-23R-CHR and construction and expression thereof
10/05/2011	CN102206663A Nucleic acid construct containing full-length genome of human hepatitis C virus and uses
10/05/2011	CN102206291A Process for extracting yam polysaccharide by using supercritical CO2 fluid extraction technique
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206243A Medical application of ursolic acid-NF (Nuclear Factor)-kappaB inhibitor
10/05/2011	CN102205121A Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
10/05/2011	CN102205114A Application of erythropoietin source peptide to preparation of medicament for treating autoimmune disease of nervous system
10/05/2011	CN102205111A Application of agrocybe aegerita galactose agglutinin to preparation of anti-HIV (Human Immunodeficiency Virus) infection medicament
10/05/2011	CN102205106A Chinese medicinal composition for treating allergic rhinitis
10/05/2011	CN102205067A Traditional Chinese medicine composition for treating chronic urticaria
10/05/2011	CN102205012A Medicament for treating allergic rhinitis and acute rhinitis
10/05/2011	CN102204981A Chinese-medicinal compound lotion for treating dermatitis eczema
10/05/2011	CN102204951A Method for extracting active components from licorice
10/05/2011	CN102204946A Chinese lobelia polysaccharide extracted from Chinese lobelia and application thereof
10/05/2011	CN102204939A Method for preparing pomegranate peel polyphenol liposome by reverse evaporation method
10/05/2011	CN102204936A Preparation method of total triterpene extract from poria cocos
10/05/2011	CN102204925A Sulfated chitosan immunopotentiator for aquaculture
10/05/2011	CN102204901A Reagent and method for regulating immune molecules
10/05/2011	CN102204883A Promethazine hydrochloride microenema prescription and preparation method thereof
10/05/2011	CN101972351B Traditional Chinese medicine for treating thrombocytopenia and Henoch-Schonlein purpura
10/05/2011	CN101953987B Chinese medicinal composition for improving chicken immunity and preparation method thereof
10/05/2011	CN101829210B Method for preparing apple polyphenol
10/05/2011	CN101810643B Goose gall extract, preparation method and medicine use thereof
10/05/2011	CN101716221B Dripping pill for increasing leucocyte
10/05/2011	CN101711848B Chinese medicinal composition capable of adjunctively treating tumour
10/05/2011	CN101642488B Scutellaria composite immune reinforcing agent, preparation method thereof and application thereof
10/05/2011	CN101601637B Pumelo leaf extract and skin cream using same
10/05/2011	CN101559095B Veterinary compound acanthopanax granules with immunopotentiation and preparation method thereof
10/05/2011	CN101507563B Production method of silk quilt capable of increasing human immunity
10/05/2011	CN101481404B Zymohydrolysis lactoprotein ferrous complex compound microcapsule iron supplement agent and preparation thereof
10/05/2011	CN101386643B Expression of vibrio alginolyticus outer membrane protein VA0760 and application thereof as vaccine component
10/05/2011	CN101361764B Composition containing brown alga polysaccharide sulfuric ester and glossy ganoderma polysaccharide and use thereof
10/05/2011	CN101301392B Chinese medicine for treating systemic lupus erythematosus and preparation thereof
10/05/2011	CN101268848B Dew concentration beverage
10/05/2011	CN101095721B Sea cucumber Chinese medicinal herb preparations for preventing diseases and increasing the weight
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030462 Immunotherapy; induce immunology response
10/04/2011	US8030459 Oxime conjugates and methods for their formation and use
10/04/2011	US8030326 Crystalline forms of rapamycin analogs
10/04/2011	US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029778 Methods of using TICAM-1, an adapter protein that binds toll-like receptor 3
10/04/2011	CA2669481C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/04/2011	CA2521038C Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
10/04/2011	CA2481770C Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis
10/04/2011	CA2467828C Pharmaceutical formulations comprising an immune response modifier
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
10/04/2011	CA2245702C Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
09/2011
09/30/2011	CA2735513A1 Stabilized pharmaceutical composition, liquid preparation of stabilized pharmaceutical composition, film-form preparation, and method for producing film-form preparation
09/29/2011	WO2011120013A2 Vista regulatory t cell mediator protein, vista binding agents and use thereof
09/29/2011	WO2011119622A1 DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1α,25- DIHYDROXYVITAMIN D3
09/29/2011	WO2011119610A2 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
09/29/2011	WO2011118957A2 Composition for treating inflammatory, allergic or asthma diseases, containing paprika extracts
09/29/2011	WO2011118804A1 Novel anti-cd98 antibody and use thereof
09/29/2011	WO2011118552A1 Anti-allergic agent
09/29/2011	WO2011118067A1 Immunostimulator comprising component derived from allium plant, process for production of immunostimulator, food composition, and immunostimulating method
09/29/2011	WO2011117160A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors
09/29/2011	WO2011116951A1 Pharmaceutically active disubstituted triazine derivatives
09/29/2011	WO2011116655A1 Antigen for increasing cd4+cd25+foxp3+ regulatory t cells and uses thereof
09/29/2011	WO2011012240A3 Lipopeptides for therapy and prophylaxis of allergic illnesses
09/29/2011	US20110238003 Method for systemic drug delivery through the nail
09/29/2011	US20110237783 Hydrazonopyrazole derivatives and their use as therapeutics
09/29/2011	US20110237688 Methods and compositions related to acetylocholine receptor conjugates
09/29/2011	US20110237681 Inhalable epinephrine
09/29/2011	US20110237651 Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
09/29/2011	US20110237650 Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
09/29/2011	US20110237647 Inhibitory rna for modulating the molecular function of zfat gene
09/29/2011	US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/29/2011	US20110237631 Selective Glycosidase Inhibitors and Uses Thereof
09/29/2011	US20110237601 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists
09/29/2011	US20110237599 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011	US20110237596 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
09/29/2011	US20110237592 Substituted amido phenoxybenzamides
09/29/2011	US20110237590 Pyridine-3-carboxyamide derivative
09/29/2011	US20110237586 Biaryl compositions and methods for modulating a kinase cascade
09/29/2011	US20110237583 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
09/29/2011	US20110237574 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/29/2011	US20110237572 Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
09/29/2011	US20110237569 SPIRO AZEPANE-OXAZOLIDINONES AS Kv1.3 POTASSIUM CHANNEL BLOCKERS
09/29/2011	US20110237565 Heterocyclic inhibitors of histamine receptors for the treatment of disease
09/29/2011	US20110237557 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
09/29/2011	US20110237550 5-azaindole bisphosphonates
09/29/2011	US20110237543 Composition for Prevention or Treatment of Eye Diseases
09/29/2011	US20110237498 Soluble polypeptides for use in treating autoimmune and inflammatory disorders
09/29/2011	US20110237497 Compositions of a v-atpase inhibitor in combination with a glucocorticoid receptor ligand and methods of use
09/29/2011	US20110236994 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/29/2011	US20110236489 Vaccine adjuvant combinations
09/29/2011	US20110236484 Genus-Wide Chlamydial Peptide Vaccine Antigens
09/29/2011	US20110236475 Granular pharmaceutical compositions
09/29/2011	US20110236470 GLUTAMYL tRNA SYNTHETASE (GtS) FRAGMENTS
09/29/2011	US20110236469 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
09/29/2011	US20110236438 Method of treatment of diseases using hoodia extracts
09/29/2011	US20110236429 Small Cationic Antimicrobial Peptides
09/29/2011	US20110236428 Combination therapy with peptide epoxyketones
09/29/2011	US20110236427 Antagonists of NR2F6 For Augmenting The Immune Response
09/29/2011	US20110236426 Pharmaceutical product for up-dosing of allergy vaccine

1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 1172